Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Neuberger Berman	NML	5. nov 2024	8.46	+2.79
Neuberger Berman High Yield Strategies Fund	NHS	5. nov 2024	8.01	+0.25
Neuberger Berman Municipal Fund	NBH	5. nov 2024	10.81	+0.75
Neuberger Berman Next Generation Connectivity Fund	NBXG	5. nov 2024	12.93	+1.09
Neuberger Berman Real Estate Securities Income Fund	NRO	5. nov 2024	3.88	+1.57
NeueHealth	NEUE	5. nov 2024	4.94	-0.40
Neumora Therapeutics	NMRA	5. nov 2024	11.91	+1.71
Neuraxis	NRXS	5. nov 2024	2.61	+0.77
Neurobo Pharmaceuticals	NRBO	5. nov 2024	2.54	+0.40
Neurocrine Biosciences	NBIX	5. nov 2024	121.53	+0.83
Neurogene	NGNE	5. nov 2024	64.40	-2.42
NeuroMetrix	NURO	5. nov 2024	3.55	-6.82
Neuronetics	STIM	5. nov 2024	1.13	+3.67
NeuroOne	NMTC	5. nov 2024	0.89	-4.13
Neuropace	NPCE	5. nov 2024	6.99	+9.73
NeuroSense Therapeutics	NRSN	5. nov 2024	1.25	+1.63
Nevro	NVRO	5. nov 2024	5.56	+3.93
New America High Income Fund	HYB	5. nov 2024	8.18	+0.12
New Concept Energy	GBR	5. nov 2024	1.14	-1.72
New England Realty Associates LP Unit A	NEN	5. nov 2024	79.00	0.00
New Fortress Energy A	NFE	5. nov 2024	8.91	+7.35
New Found Gold	NFGC	5. nov 2024	2.23	-0.89
New Germany Fund	GF	5. nov 2024	8.53	+0.71
New Gold	NGD	5. nov 2024	2.74	-0.72
New Horizon Aircraft	HOVR	5. nov 2024	0.27	-0.65
New Mountain Finance Corp	NMFC	5. nov 2024	10.68	-1.11
New Oriental Education & Technology Group ADR	EDU	5. nov 2024	61.87	-0.85
New Pacific Metals	NEWP	5. nov 2024	1.62	-2.41
New Providence Acquisition II A	NPAB	5. nov 2024	11.20	0.00
New Providence Acquisition II Unit	NPABU	5. nov 2024	12.20	-1.61

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.